Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IB Randomized Study of an Antiestrogen in Women With Newly Diagnosed Breast Cancer

NCT00005886 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT00005886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IB Randomized Study of an Antiestrogen in Women With Newly Diagnosed Breast Cancer
Lead sponsor
University of Kansas Medical Center
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2000
Completion date
August 31, 2002
Enrollment
Not reported
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer